Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects.
SMS 201 995 is a new long acting analogue of somatostatin. We have investigated its effect on basal and meal stimulated secretion of gut hormones and have shown that after a single s.c. injection of 50 micrograms it lowers significantly the basal plasma levels of pancreatic polypeptide, secretin, motilin, pancreatic glucagon and insulin, it also effectively suppresses the postprandial release of pancreatic polypeptide, gastrin, secretin, gastric inhibitory peptide, pancreatic glucagon and insulin. Except for the usual brief discomfort of an injection, no symptoms or untoward effects were observed.
Kraenzlin
M E
ME
Wood
S M
SM
Neufeld
M
M
Adrian
T E
TE
Bloom
S R
SR
D000328:Adult; D005502:Food; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism; D005755:Gastrins / Q000378:metabolism; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D005934:Glucagon / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007700:Kinetics; D008297:Male; D009037:Motilin / Q000378:metabolism; D015282:Octreotide; D010191:Pancreatic Polypeptide / Q000378:metabolism; D012633:Secretin / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000494:pharmacology
D005755:Gastrins; D005768:Gastrointestinal Hormones; D007328:Insulin; D012633:Secretin; D013004:Somatostatin; D009037:Motilin; D005749:Gastric Inhibitory Polypeptide; D010191:Pancreatic Polypeptide; D005934:Glucagon; D015282:Octreotide